Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.71 USD | -1.95% | -20.46% | -20.24% |
Kurzporträt
Mitarbeiterzahl: 6
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20.11.18 |
David Katzoff
DFI | Director of Finance/CFO | 63 | 01.11.19 |
William Horne
CHM | Chairman | 55 | 01.06.16 |
Henry Nisser
BRD | Director/Board Member | 56 | 01.05.19 |
James Turner
LAW | General Counsel | 49 | 01.04.21 |
Kenneth Cragun
PRN | Corporate Officer/Principal | 63 | 01.10.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Mark Gustafson
BRD | Director/Board Member | 64 | 01.06.21 |
Todd Ault
FOU | Founder | 54 | 25.02.16 |
William Horne
CHM | Chairman | 55 | 01.06.16 |
Jeffrey Oram
BRD | Director/Board Member | 56 | 01.06.21 |
Henry Nisser
BRD | Director/Board Member | 56 | 01.05.19 |
Lynne McGrath
BRD | Director/Board Member | 69 | 01.06.21 |
Stephan Jackman
CEO | Chief Executive Officer | 48 | 20.11.18 |
Andrew Woo
BRD | Director/Board Member | 61 | 01.06.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 6 866 846 | 4 831 824 ( 70,36 %) | 0 | 70,36 % |
Unternehmenskontakt
Alzamend Neuro, Inc.
3480 Peachtree Road NE Suite 103
30326, Atlanta
+844 722 6333
http://www.alzamend.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-20.24% | 4.97 Mio. | |
-1.32% | 41.36 Mrd. | |
+45.38% | 41.3 Mrd. | |
+3.02% | 39.61 Mrd. | |
-15.14% | 25.62 Mrd. | |
+3.84% | 24.09 Mrd. | |
-23.74% | 18.38 Mrd. | |
+24.62% | 11.85 Mrd. | |
-2.55% | 11.82 Mrd. | |
+8.27% | 11.07 Mrd. |
- Börse
- Aktien
- A3EYCP Aktie
- Unternehmen Alzamend Neuro, Inc.